TATVA — Tatva Chintan Pharma Chem Balance Sheet
0.000.00%
- IN₹16.84bn
- IN₹16.84bn
- IN₹3.94bn
Annual balance sheet for Tatva Chintan Pharma Chem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 119 | 64.8 | 638 | 412 | 457 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 516 | 926 | 694 | 968 | 881 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,327 | 1,843 | 4,359 | 3,123 | 2,979 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,160 | 1,302 | 2,108 | 4,265 | 5,031 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 2,489 | 3,148 | 6,583 | 7,589 | 8,187 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 877 | 1,180 | 1,714 | 2,387 | 797 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 1,312 | 1,488 | 1,852 | 2,441 | 816 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 1,177 | 1,660 | 4,731 | 5,148 | 7,371 |
Total Liabilities & Shareholders' Equity | 2,489 | 3,148 | 6,583 | 7,589 | 8,187 |
Total Common Shares Outstanding |